Skip to main content
. 2011 Dec 21;6(12):e28908. doi: 10.1371/journal.pone.0028908

Figure 4. In vitro application of ARTN decreased ATF3 expression in GFRα3-positive neurons.

Figure 4

In control conditions, most GFRα3-positive neurons expressed ATF3 at 1 d (96.7±0.5%) (A–C, arrows) and 4 d (97.2±0.4%) (G–I; arrows) after plating. Addition of ARTN significantly decreased the percentage of GFRα3-positive neurons that expressed ATF3 at 1 d (8.7±0.3%) (D–F; arrowheads) and 4 d (8.9±0.4%) (J–L; arrowheads). Scale bar = 50 µm. Two way ANOVA, p<0.01.